GOLETA, Calif.–(BUSINESS WIRE)–$INGN #AirwayClearance—Inogen, Inc. (Nasdaq: INGN), a number one medical know-how firm providing revolutionary respiratory merchandise to be used within the homecare setting, immediately introduced the appointment of Naga Rameswamy as Chief Know-how Officer, efficient September 29, 2025. Mr. Rameswamy joins Inogen from Alcon, the place he served because the Vice President and International Head of Digital Well being Platforms.
“Naga’s deep background in digital well being and linked system innovation makes him a perfect match for Inogen as we proceed to increase our know-how management,” mentioned Kevin Smith, President and Chief Govt Officer of Inogen, “His capability to combine software program, knowledge, and gadgets to enhance consumer experiences can be instrumental in advancing our pipeline and strengthening our aggressive positioning in immediately’s underserved respiratory care market. We look ahead to his contributions as a key member of our management workforce.”
Mr. Rameswamy brings greater than twenty years of management within the medical system trade spanning innovation, R&D, and digital transformation. Previous to Alcon, he spent almost twenty years at GE Healthcare, culminating as Vice President of Digital Well being Engineering. He has superior safe system connectivity, distant diagnostics, fleet reliability, and care administration platforms throughout diagnostic imaging, ultrasound, and affected person monitoring modalities. He has scaled world engineering groups and partnered intently with high quality, regulatory, manufacturing, gross sales, service, and cloud infrastructure to ship compliant, safe, and intuitive merchandise & options that enhance serviceability, lengthen product lifecycles, and improve experiences for sufferers, caregivers, and clinicians.
“I’m honored to affix Inogen and its distinctive workforce. The corporate’s mission in respiratory care, its world attain, and its platform of trusted merchandise present a robust basis for continued impression,” mentioned Mr. Rameswamy, “I look ahead to advancing our digital well being and know-how initiatives, constructing on the spectacular packages already in place to ship higher experiences for sufferers and companions as we attain extra individuals affected by respiratory circumstances.”
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a number one world medical know-how firm providing revolutionary respiratory merchandise to be used within the homecare setting. Inogen helps affected person respiratory care by creating, manufacturing, and advertising revolutionary best-in-class respiratory remedy gadgets used to ship care to sufferers affected by continual respiratory circumstances. Inogen companions with sufferers, prescribers, dwelling medical gear suppliers, and distributors to make its respiratory remedy merchandise broadly obtainable, permitting sufferers the prospect to handle the impression of their illness.
For extra info, please go to www.inogen.com.
Ahead-Trying Statements
This press launch incorporates forward-looking statements throughout the which means of the Non-public Securities Litigation Reform Act of 1995. All statements contained on this communication that aren’t historic information, together with, however not restricted to, statements relating to Inogen’s future enterprise plans, market alternatives, monetary outlook, progress methods, and anticipated operational outcomes, are forward-looking statements. Phrases akin to “goals,” “believes,” “anticipates,” “plans,” “expects,” “will,” “intends,” “potential,” “attainable,” and comparable expressions are meant to determine forward-looking statements. Ahead-looking statements are topic to quite a few dangers and uncertainties that would trigger precise outcomes to vary materially from presently anticipated outcomes, together with however not restricted to, dangers and uncertainties regarding the potential advantages of Inogen’s collaboration with Yuwell; market acceptance of its merchandise; competitors; its gross sales, advertising and distribution capabilities; its deliberate gross sales, advertising, and analysis and growth actions; and dangers related to worldwide operations. Data on these and extra dangers, uncertainties, and different info affecting Inogen’s enterprise working outcomes are contained in its Annual Report on Kind 10-Okay for the interval ended December 31, 2024, and in its different filings with the Securities and Change Fee. These forward-looking statements converse solely as of the date hereof. Inogen disclaims any obligation to replace these forward-looking statements besides as could also be required by legislation.
Contacts
